Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Yi Zang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4463-0939; OpenAlex author ID A5023681774, A5130919975. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
22
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 6

  1. Chrysosplenetin-induced TMED3 aggregation triggers unfolded protein response in pancreatic cancer. Co-author DOI 10.1038/s44321-026-00506-5↗
  2. Nano-enabled repurposing of Benproperine phosphate enhances pancreatic Cancer chemotherapy through lethal autophagy arrest and immune activation. Co-author DOI 10.1016/j.jconrel.2025.114187↗
  3. SKA1 regulates actin cytoskeleton remodelling via activating Cdc42 and influences the migration of pancreatic ductal adenocarcinoma cells. Co-author DOI 10.1111/cpr.12799↗
  4. EI24 Suppresses Tumorigenesis in Pancreatic Cancer via Regulating c-Myc. Co-author DOI 10.1155/2018/2626545↗
  5. Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress. Co-author DOI 10.18632/oncotarget.19402↗
  6. Smad4-dependent suppressor pituitary homeobox 2 promotes PPP2R2A-mediated inhibition of Akt pathway in pancreatic cancer. Co-author DOI 10.18632/oncotarget.7158↗

Closest collaborators

The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ningna Weng · 1 shared paper, 2026 · strength 0.26
  2. Zhe Zhang · 1 shared paper, 2026 · strength 0.26
  3. Qi Zhang · 1 shared paper, 2026 · strength 0.26
  4. Tingbo Liang · 1 shared paper, 2026 · strength 0.26
  5. Lifu Wang · 3 shared papers, 2016–2020 · strength 0.23
  6. Xiaobao Wei · 1 shared paper, 2025 · strength 0.20
  7. Jiangchao Wu · 1 shared paper, 2025 · strength 0.20
  8. Mengyao Dai · 1 shared paper, 2025 · strength 0.20
  9. Zhe Zhang · 1 shared paper, 2025 · strength 0.20
  10. Qi Zhang · 1 shared paper, 2025 · strength 0.20
  11. Tingbo Liang · 1 shared paper, 2025 · strength 0.20
  12. Qi Wang · 2 shared papers, 2016–2020 · strength 0.15
  13. Tong Li · 1 shared paper, 2020 · strength 0.10
  14. Xu Liu · 1 shared paper, 2020 · strength 0.10
  15. Lei Zhu · 1 shared paper, 2018 · strength 0.07
  16. Xiao Hua Su · 1 shared paper, 2017 · strength 0.06
  17. Ping Chen · 1 shared paper, 2017 · strength 0.06
  18. Qiwen Ben · 1 shared paper, 2017 · strength 0.06
  19. Wei‐Guang Li · 1 shared paper, 2017 · strength 0.06
  20. Xiangyi He · 1 shared paper, 2017 · strength 0.06
  21. Yaozong Yuan · 1 shared paper, 2017 · strength 0.06
  22. Weiyan Yao · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.